Reset filter

ANZCA Pholcodine Statement September 2023

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

PS40(G)BP Position statement on relationship between fellows, trainees and healthcare industry BP

PS40(G)BP Position statement on the relationship between fellows, trainees and the healthcare industry Background Paper

Gender Metrics Report 2023

Gender Metrics Report 2023

ANZCA submission RCoIC

New Zealand National Committee feedback on experiences during and lessons learned from the COVID-19 pandemic.

Latest PoM Communiqué

PoM communique October2019

Social media policy

ANZCA social media policy

ANZCA Bulletin December 2019

ANZCA Bulletin Autumn 2022

Into the deep with a breakthrough consciousness study | COVID-19: How we’re working and living with the virus two years on | Beyond city limits: Twin cities provide regional opportunities for trainees

ANZCA Bulletin June 2018

First  < Prev   ... 21 22 23 24 25 26 27 28 29    Next >  Last Pages: 21 of 29